Nomura Research Institute Ltd ADR (NRILY)

Nomura Research Institute Ltd ADR is a depositary receipt representing common stock of Nomura Research Institute, Ltd., which is listed on OTC Markets under ticker NRIL.Y. The underlying company provides IT and consulting services in Japan and internationally. Its business is organized across consulting, financial IT solutions, industrial IT solutions, and IT platform services. The consulting division covers management, organizational reform, and systems consulting related to IT governance. The financial IT unit serves banks, securities firms, insurers, and other financial institutions with system consulting, development, management, shared online services, and BPO support. The industrial IT segment works with clients in distribution, manufacturing, services, and the public sector. The IT platform business includes data center operations, network and platform construction, information security services, and related infrastructure support. Nomura Research Institute was founded in 1965 and is headquartered in Tokyo, Japan.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-NRIL.Y
$27.99
-13.2% Downside
Fair
$39.35
22.0% Upside
Undervalued
Good
0.0%
October 29, 2026
156.2x
7.7x
3.5x
18.332 B
18.407 B
7.5%
68.8%
7.4
239.2%
822.5%
Valuation • Fair Value

Nomura Research Institute Ltd ADR (OTC-NRIL.Y) Fair Value by Valuation Model

Review the available estimates for Nomura Research Institute Ltd ADR (OTC-NRIL.Y), including DCF Fair Value, Ben Graham Formula Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$27.99

Estimated downside of 13.2% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$30.81

Discounted cash flow valuation reference.

Ben Graham Formula Value

$2.33

Classic Ben Graham valuation formula reference.

EPV Fair Value

$17.40

Earnings power value estimate.

Comps Fair Value

$26.92

Comparable-company valuation reference.

Analyst Price Target

$39.35

Analysts imply upside of 22.0%.

How to read these valuation models

Use the 7 available valuation references for Nomura Research Institute Ltd ADR (OTC-NRIL.Y) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Nomura Research Institute Ltd ADR (OTC-NRIL.Y)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

5.101 B

Current operating scale indicator.

Revenue Forecast

5.493 B

Forward revenue estimate.

EBITDA

698.4 M

Current operating profitability reference.

EBITDA Forecast

1.461 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Nomura Research Institute Ltd ADR (OTC-NRIL.Y) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Nomura Research Institute Ltd ADR (OTC-NRIL.Y)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-3.39

No elevated caution signal from this screen.

Altman Z-Score

7.4

Relatively strong balance-sheet zone.

FCF / Net Income

822.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Nomura Research Institute Ltd ADR (OTC-NRIL.Y). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Nomura Research Institute Ltd ADR (OTC-NRIL.Y)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

October 29, 2026

Days to Earnings

37

Dividend Yield

0.0%

No current dividend yield is indicated.

Payout Ratio

239.2%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Nomura Research Institute Ltd ADR (OTC-NRIL.Y), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Nomura Research Institute Ltd ADR (OTC-NRIL.Y) Stock Forecast & Technical Outlook

Review Nomura Research Institute Ltd ADR (OTC-NRIL.Y) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Nomura Research Institute Ltd ADR (OTC-NRIL.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Nomura Research Institute Ltd ADR (OTC-NRIL.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Nomura Research Institute Ltd ADR (OTC-NRIL.Y) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Nomura Research Institute Ltd ADR (OTC-NRIL.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Neutral

The monthly technical read for Nomura Research Institute Ltd ADR (OTC-NRIL.Y) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Nomura Research Institute Ltd ADR (OTC-NRIL.Y)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Nomura Research Institute Ltd ADR (OTC-NRIL.Y) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ Fast Investor Answers

Nomura Research Institute Ltd ADR (OTC-NRIL.Y) Stock FAQ

Data-supported answers about Nomura Research Institute Ltd ADR (OTC-NRIL.Y), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$27.99
Estimated downside 13.2%
Valuation Rating
Overvalued
Estimated downside of 13.2%
Analyst Target
$39.35
Implied upside 22.0%
Financial Health
Good
Current financial-health read

The current fair value estimate for Nomura Research Institute Ltd ADR (OTC-NRIL.Y) is $27.99. This implies an estimated downside of 13.2% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 13.2% versus the current market price.

The available analyst price target for Nomura Research Institute Ltd ADR (OTC-NRIL.Y) is $39.35. The analyst target implies estimated upside of 22.0%.

The current financial health read for Nomura Research Institute Ltd ADR (OTC-NRIL.Y) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Nomura Research Institute Ltd ADR (OTC-NRIL.Y) is October 29, 2026.

The latest available data indicates no current dividend yield for Nomura Research Institute Ltd ADR (OTC-NRIL.Y).

The current P/E ratio listed for Nomura Research Institute Ltd ADR (OTC-NRIL.Y) is 156.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Nomura Research Institute Ltd ADR is 18.332 B.

The current enterprise value listed for Nomura Research Institute Ltd ADR is 18.407 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Nomura Research Institute Ltd ADR is OTC-NRIL.Y, and the stock is listed on OTC Markets.

Nomura Research Institute Ltd ADR (OTC-NRIL.Y) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Nomura Research Institute Ltd ADR is 7.5%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Nomura Research Institute Ltd ADR is 68.8%. Free float helps investors understand how much of the share base is available for public trading.